Biotechnology | FDA | Oncology | Therapeutics
The FDA approved Amgen’s Epogen/Procrit for the treatment of anemia
On Apr. 1, 1993, the U.S. Food and Drug Administration (FDA) approved Amgen’s Epogen/Procrit for the treatment of…
On Apr. 1, 1993, the U.S. Food and Drug Administration (FDA) approved Amgen’s Epogen/Procrit for the treatment of…